Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iscador plus standard treatment versus standard treatment alone in sarcoma
IRCT20240121060752N1Phase 4Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial of viscum album in bone cancer and soft tissue sarcoma (STS) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Local recurrence control, Quality of life and 2 more. Started Feb 2024; status: completed.
02
Drugs
viscum album
03
Conditions
bone cancersoft tissue sarcoma (STS)
Beyond the preview
Go deeper on IRCT20240121060752N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240121060752N1.